Literature DB >> 3873195

A case of invasive penicilliosis in Hong Kong with immunologic evaluation.

S Y So, P Y Chau, B M Jones, P C Wu, K K Pun, W K Lam, J W Lawton.   

Abstract

A 53-yr-old Chinese sailor developed prolonged pyrexia with unresolved lobar pneumonia, cervical lymphadenopathy, generalized subcutaneous abscesses, and pericardial effusion. Penicillium marneffei was isolated from pericardial fluid and subcutaneous pus and was demonstrated on histologic sections of lymph nodes and lung tissue. The penicilliosis was treated successfully with amphotericin B, ketoconazole, and 5-fluorocytosine. Subsequently, he also developed other T-lymphocyte-related opportunistic infections such as disseminated cutaneous herpes zoster and chronic osteomyelitis of sternum caused by Salmonella typhimurium. He was also a chronic carrier of cytomegalovirus. Further investigations showed that he had persistent depression of T-lymphocyte function and enhancement of B-lymphocyte activity, the cause of which was undetermined.

Entities:  

Mesh:

Year:  1985        PMID: 3873195     DOI: 10.1164/arrd.1985.131.4.662

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  10 in total

1.  Fifteen cases of penicilliosis in Guangdong, China.

Authors:  Xi Liyan; Lu Changming; Zhou Xianyi; Wang Luxia; Xie Suisheng
Journal:  Mycopathologia       Date:  2004-08       Impact factor: 2.574

Review 2.  Penicillium marneffei infection and recent advances in the epidemiology and molecular biology aspects.

Authors:  Nongnuch Vanittanakom; Chester R Cooper; Matthew C Fisher; Thira Sirisanthana
Journal:  Clin Microbiol Rev       Date:  2006-01       Impact factor: 26.132

3.  Penicillium marneffei: types and drug susceptibility.

Authors:  P Imwidthaya; K Thipsuvan; A Chaiprasert; S Danchaivijitra; R Sutthent; J Jearanaisilavong
Journal:  Mycopathologia       Date:  2001       Impact factor: 2.574

Review 4.  Fungal infections of the immunocompromised host: clinical and laboratory aspects.

Authors:  C E Musial; F R Cockerill; G D Roberts
Journal:  Clin Microbiol Rev       Date:  1988-10       Impact factor: 26.132

5.  Differences in clinical and laboratory diagnostic characteristics of penicilliosis marneffei in human immunodeficiency virus (HIV)- and non-HIV-infected patients.

Authors:  S S Wong; K H Wong; W T Hui; S S Lee; J Y Lo; L Cao; K Y Yuen
Journal:  J Clin Microbiol       Date:  2001-12       Impact factor: 5.948

6.  Restriction endonuclease analysis of Penicillium marneffei.

Authors:  N Vanittanakom; C R Cooper; S Chariyalertsak; S Youngchim; K E Nelson; T Sirisanthana
Journal:  J Clin Microbiol       Date:  1996-07       Impact factor: 5.948

7.  Treatment and serological studies of an Italian case of penicilliosis marneffei contracted in Thailand by a drug addict infected with the human immunodeficiency virus.

Authors:  M A Viviani; A M Tortorano; G Rizzardini; T Quirino; L Kaufman; A A Padhye; L Ajello
Journal:  Eur J Epidemiol       Date:  1993-01       Impact factor: 8.082

8.  In vitro sensitivity of Penicillium marneffei and Pythium insidiosum to various antifungal agents.

Authors:  A S Sekhon; A A Padhye; A K Garg
Journal:  Eur J Epidemiol       Date:  1992-05       Impact factor: 8.082

9.  Response to antifungal therapy by human immunodeficiency virus-infected patients with disseminated Penicillium marneffei infections and in vitro susceptibilities of isolates from clinical specimens.

Authors:  K Supparatpinyo; K E Nelson; W G Merz; B J Breslin; C R Cooper; C Kamwan; T Sirisanthana
Journal:  Antimicrob Agents Chemother       Date:  1993-11       Impact factor: 5.191

Review 10.  Talaromyces (Penicillium) marneffei infection in non-HIV-infected patients.

Authors:  Jasper F W Chan; Susanna K P Lau; Kwok-Yung Yuen; Patrick C Y Woo
Journal:  Emerg Microbes Infect       Date:  2016-03-09       Impact factor: 7.163

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.